Prognostic Value of Platelet-to-Lymphocyte Ratio Combined with CHA2DS2-VASc Score for Nonvalvular Atrial Fibrillation Induced Cardiogenic Cerebral Embolism
Qian Fan,Ling Gao,Zhiquan Wang,Fabrice Yves Ndjana Lessomo,Gang Wang
DOI: https://doi.org/10.2147/jir.s431149
IF: 4.5
2023-12-06
Journal of Inflammation Research
Abstract:Qian Fan, 1, &ast Ling Gao, 1, &ast Zhiquan Wang, 2, &ast Fabrice Yves Ndjana Lessomo, 2 Gang Wang 1 1 Department of Cardiology, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, People's Republic of China; 2 Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Gang Wang, Email Aim: To determine the predictive significance of the platelet-to-lymphocyte ratio (PLR) combined with the CHA 2 DS 2 -VAS c score for cardiogenic cerebral embolism (CCE) in patients with nonvalvular atrial fibrillation (NVAF). Methods: A total of 553 patients with NVAF were included in this retrospective study. The general data, PLR, CHA 2 DS 2 -VAS c score and echocardiography indicators were compared. The risk factors for CCE and the predictive value of PLR and CHA 2 DS 2 -VAS c were analyzed. Stratified analysis was performed based on the cut-off value. Least absolute shrinkage and selection operator (LASSO) regression analysis was utilized to build a model. The relationship between risk score and different anticoagulants was evaluated. Results: Multiple regression analysis showed hypertension (OR=3.95, 95% CI=2.12– 7.35, p =1.40× 10 − 5 ), diabetes mellitus (OR=2.95, 95% CI=1.57– 5.58, p =7.65× 10 − 4 ), PLR (OR=1.01, 95% CI=1.00– 1.01, p < 10 − 6 ), creatinine level (OR=1.01, 95% CI=1.00– 1.02, p =7.44× 10 − 3 ), left atrial diameter (LAD) (OR=1.90, 95% CI=1.13– 3.19, p =1.51× 10 − 2 ), ejection fraction (EF) (OR=0.93, 95% CI=0.87– 0.98, p =8.06× 10 − 3 ) and CHA 2 DS 2 -VAS c score (OR=3.79, 95% CI=2.95– 4.85, p < 10 − 6 ) were independent risk factors for CCE. A one-way linear analysis also showed the above seven indexes were significantly correlated with CCE ( F =56.4, p < 10 − 6 ). The area under the receiver operating characteristic (ROC) curve of PLR and CHA 2 DS 2 -VAS c score was 0.760 (95% CI:0.721– 0.800), and 0.855 (95% CI: 0.824– 0.886), respectively. Pearson correlation analysis showed that PLR was correlated with CHA 2 DS 2 -VAS c score (r=0.331, p < 10 − 6 ). Stratified analysis indicated there was a positive correlation between different risk group ( p < 10 − 6 ). Using the LASSO model, a composite indicator displayed differential power for distinguishing CCE with an AUC value of 0.884 (95% CI: 0.857– 0.911). Patients with dabigatran and rivaroxaban exhibited higher risk score than those with warfarin (warfarin vs dabigatran, p =1.40× 10 − 2 ; warfarin vs rivaroxaban p =3.00× 10 − 3 ). Conclusion: PLR and CHA 2 DS 2 -VAS c score are independent risk factors for CCE with NVAF, and the combination of the two indices can improve the prediction of CCE. Keywords: NVAF, CCE, PLR, CHA 2 DS 2 -VAS c score, LASSO model Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice and is characterized by cardiac systolic dysfunction, rapid and disordered atrial electrical activity, and atrial mural thrombosis. 1 Due to the prevalence of population ageing and risk factors such as hypertension, diabetes, obesity, smoking and alcohol consumption, the prevalence of AF has been increasing significantly. 2–5 NVAF is one of the most common type major causes of atrial fibrillation, accounting for 65.2% of cases, and the incidence rate shows an increasing trend year by year. Thromboembolic complications are the main cause of death and disability in NVAF. 6 The risk of stroke in patients suffering from NVAF is five times higher than that in the general population. NVAF causes more acute onset of cerebral infarction and higher mortality and disability than other types of cerebral infarction, and imposes a great burden on global public health. 7,8 Current guidelines agree that the prevention of AF-related cerebral infarction is the primary concern of comprehensive management strategy and treatment guidance for patients. Due to the seriousness of the danger of AF, early identification of high-risk patients is needed, and in addition to traditional approaches, some new clues have been gradually discovered, such as fragmented QFR. 9,10 The mechanism of the generati -Abstract Truncated-
immunology